Beryl Drugs

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue6.295.645.405.224.83
Expenses5.795.535.245.124.77
EBITDA0.980.560.590.500.55
EBIT0.710.230.280.180.17
Profit Before Tax0.500.110.160.100.07
Net Profit0.370.010.050.150.02
Financial Ratios
Operating Profit Margin15.84%10.16%11.11%12.59%11.48%
Net Profit Margin5.92%0.18%0.94%3.78%0.42%
Earning Per Share (Diluted)0.730.010.100.300.04
Dividends Per Share0.000.000.000.000.00